ScholarIQanswers from OpenAlex

COVID-19-neutralizing antibodies predict disease severity and survival

PaperCitations, authors & open-access status

COVID-19-neutralizing antibodies predict disease severity and survival is a paper indexed in ScholarIQ from OpenAlex.

How many citations does COVID-19-neutralizing antibodies predict disease severity and survival have?

ScholarIQcitation count

COVID-19-neutralizing antibodies predict disease severity and survival has 793 citations in the OpenAlex counts ScholarIQ stores.

When was COVID-19-neutralizing antibodies predict disease severity and survival published?

ScholarIQyear

COVID-19-neutralizing antibodies predict disease severity and survival has 2020 year in the ScholarIQ index.

What is the open-access status of COVID-19-neutralizing antibodies predict disease severity and survival?

ScholarIQoa status

COVID-19-neutralizing antibodies predict disease severity and survival has bronze oa status in the ScholarIQ index.

What is the DOI of COVID-19-neutralizing antibodies predict disease severity and survival?

ScholarIQdoi

The DOI for COVID-19-neutralizing antibodies predict disease severity and survival is on the source record.

What is the PMID of COVID-19-neutralizing antibodies predict disease severity and survival?

ScholarIQpmid

The PMID for COVID-19-neutralizing antibodies predict disease severity and survival is on the source record.

What is the OpenAlex record for COVID-19-neutralizing antibodies predict disease severity and survival?

ScholarIQopenalex

The OpenAlex for COVID-19-neutralizing antibodies predict disease severity and survival is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial